XPA Antibody (2A4) [Allophycocyanin]
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-50600APC
Conjugate
Catalog #
Forumulation
Catalog #
Key Product Details
Species Reactivity
Validated:
Human
Applications
Immunocytochemistry/ Immunofluorescence, Immunohistochemistry, Western Blot
Label
Allophycocyanin (Excitation = 620-650 nm, Emission = 660-670 nm)
Antibody Source
Monoclonal Mouse IgG1 Clone # 2A4
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Summary for XPA Antibody (2A4) [Allophycocyanin]
Immunogen
His-tagged recombinant human XPA protein.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG1
Applications for XPA Antibody (2A4) [Allophycocyanin]
Application
Recommended Usage
Immunocytochemistry/ Immunofluorescence
Optimal dilutions of this antibody should be experimentally determined.
Immunohistochemistry
Optimal dilutions of this antibody should be experimentally determined.
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A purified
Formulation
PBS
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: XPA
Long Name
Xeroderma Pigmentosum, Complementation Group A
Alternate Names
XP1
Gene Symbol
XPA
Additional XPA Products
Product Documents for XPA Antibody (2A4) [Allophycocyanin]
Product Specific Notices for XPA Antibody (2A4) [Allophycocyanin]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...